🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.1636
-0.0230 (-12.33%)
At close: Nov 20, 2026, 4:00 PM EST
0.1666
+0.0030 (1.83%)
After-hours: Nov 20, 2026, 7:46 PM EST

Vistagen Therapeutics Balance Sheet

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
10.8930.7967.13119.1716.6468.14
Short-Term Investments
9.1414.6113.35---
Cash & Short-Term Investments
20.0345.480.48119.1716.6468.14
Cash Growth
-74.04%-43.59%-32.46%616.23%-75.58%-33.92%
Other Receivables
-----0.34
Receivables
-----0.34
Prepaid Expenses
2.261.541.591.510.80.2
Other Current Assets
----0.072.33
Total Current Assets
22.2946.9482.08120.6717.5171
Property, Plant & Equipment
0.841.231.812.262.773.08
Long-Term Deferred Charges
-0.060.13-0.710.47
Other Long-Term Assets
0.290.340.320.730.10.1
Total Assets
23.4248.5684.34123.6521.0974.64

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
1.081.540.651.552.472.76
Accrued Expenses
6.648.768.812.240.81.33
Short-Term Debt
-0.1--0.11-
Current Portion of Leases
0.610.70.560.550.490.43
Current Unearned Revenue
0.11.712.590.790.711.24
Total Current Liabilities
8.4312.812.615.124.575.77
Long-Term Leases
-0.250.951.572.122.61
Long-Term Unearned Revenue
--0.392.672.321.56
Total Liabilities
8.4313.0413.959.379.019.93

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
0.050.040.030.030.010.01
Additional Paid-In Capital
520.01516.77481.96474.44342.89336.28
Retained Earnings
-501.09-477.32-407.63-356.21-326.85-267.6
Treasury Stock
-3.97-3.97-3.97-3.97-3.97-3.97
Comprehensive Income & Other
-0.01-00.01---
Total Common Equity
14.9935.5270.39114.2912.0864.72
Shareholders' Equity
14.9935.5270.39114.2912.0864.72
Total Liabilities & Equity
23.4248.5684.34123.6521.0974.64

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
0.611.041.512.122.713.04
Net Cash (Debt)
19.4244.3678.97117.0513.9365.1
Net Cash Growth
-74.21%-43.83%-32.53%740.43%-78.61%-34.50%
Net Cash Per Share
0.451.172.566.052.009.86
Filing Date Shares Outstanding
46.1941.0329.1627.037.876.89
Total Common Shares Outstanding
45.5939.622927.037.316.88
Working Capital
13.8734.1569.46115.5512.9365.23
Book Value Per Share
0.330.902.434.231.659.40
Tangible Book Value
14.9935.5270.39114.2912.0864.72
Tangible Book Value Per Share
0.330.902.434.231.659.40
Machinery
-1.121.61.481.491.45
Leasehold Improvements
-0.190.220.210.210.21
SEC Filings: 10-K · 10-Q